This manuscript provides experimental evidence to support the claim that PIF induces proteasome expression through activation of nuclear binding of NF-κB. Thus, agents capable of inhibiting activation of NF-κB should potentially be capable of inhibiting muscle protein degradation in cancer cachexia if PIF is involved. The gene discussed is DCD; the disease is cancer.